Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: Implications for a clinically relevant tumor vaccine

Human Gene Therapy

Volumn 7, Issue 13, 1996, Pages 1535-1543

  Mahvi, David M ^a,b   Burkholder, Joseph K ^c   Turner, Joel ^c   Culp, Jerilyn ^c   Malter, James S ^b,d   Sondel, Paul M ^a,b   Yang, Ning Sun ^c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c Agracetus   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; COMPLEMENTARY DNA; CYTOKINE; GOLD; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLISTIC TRANSFORMATION; CANCER; CONTROLLED STUDY; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MELANOMA B16; MELANOMA CELL; MOUSE; NONHUMAN; NUDE MOUSE; PLASMID; TISSUE CULTURE; TUMOR CELL;

EID: 0029779577     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.13-1535     Document Type: Article

References (26)

1. BERNS, A.J., CLIFT, S., COHEN, L.K., DONEHOWER, R.C., DRANOFF, G., HAUDA, K.M., JAFFEE, E.M., LAZENBY, A.J., LEVITSKY, H.I., MARSHALL, F.F., MULLIGAN, R.C., NELSON, W.G., OWENS, A.H., PARDOLL, D.M., PARRY, G., PARTIN, A.H., PIANTADOSI, S., SIMONS, J.W., and ZOBORA, J.R. (1995). Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma. Hum. Gene Ther. 6, 347-368.
2. BORDEN, E.C., and SONDEL, P.M. (1990). Lymphokines and cytokines as cancer treatment. Immunotherapy realized. Cancer 65, 800-814.
3. BURKHOLDER, J.K., DECKER, J., and YANG, N.-S. (1993). Rapid transgene expression in lymphocyte and macrophage primary cultures after particle-bombardment-mediated gene transfer. J. Immunol. Methods 165, 149-156.
4. CAVALLO, F., DIPIERRO, F., GIOVARELLI, M., GULINO, A., VACCA, A., STOPPACCIARO, A., FORNI, M., MODESTI, A., and FORNI, G. (1993). Protective and curative potential of vaccination with interleukin-2 gene-transfected cells from a spontaneous mouse mammary adenocarcinoma. Cancer Res. 53, 5067-5070.
5. CHENG, L., SUN, J., PRETLOW, T.G., CULP, J., and YANG, N.-S. (1996). CWR22 xenograft as an in vivo human tumor model for prostate cancer gene therapy. J. Natl. Cancer Inst. 88, 607-611.
6. CORTESINA, G., DE STEFANI, A., GIOVARELLI, M., BARIOGLIO, M.G., CAVALLO, G.P., JEMMA, C., and FORNI, G. (1988). Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphatically. Cancer 62, 2482-2485.
7. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539-3543.
8. HANK, J.A., ALBERTINI, M., WESLY, O.H., SCHILLER, J.H., BORCHERT, A., MOORE, K., BECHHOFER, R., STORER, B., GAN, J., GAMBACORTI, C., SOSMAN, J., and SONDEL, P.M. (1995). Clinical and immunologic effects of treatment with murine anti-CD3 monoclonal antibody together with interleukin-2 in patients with cancer. Clin. Cancer Res. 1, 481-491.
9. JIAO, S., CHENG, L., WOLFF, J.A., and YANG, N.-S. (1993). Particle bombardment-mediated gene transfer and expression in rat brain tissues. Bio/Technology 11, 497-502.
10. KEMMNER, W., SCHLAG, P., and BROSSMER, R. (1987). A rapid and simple procedure for dissocation of tumor tissue from the human colon. J. Cancer Res. Clin. Oncol. 113, 400-401.
11. MILLER, D.G., ADAM, M.A., and MILLER, A.D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242.
12. MULÉ, J.J., YANG, J.C., LAFRENIERE, R.L., SHU, S., and ROSENBERG, S.A. (1987). Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the, systemic administration of high dose recombinant interleukin-2. J. Immunol. 139, 285-294.
13. PARKINSON, D.R. (1990). Lessons from the clinical trials of interleukin-2. Natl. Immunol. Cell Growth Regul. 9, 242-252.
14. PERTMER, T.M., EISENBRAUN, M.D., MCCABE, D., PRAYAGA, S.K., FULLER, D.H., and HAYNES, J.R. (1995). Gene gun-based nucleic acid immunization: Elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13, 1427-1430.
15. RAJAGOPALAN, L.E., BURKHOLDER, J.K., TURNER, J., CULP, J., YANG, N.-S., and MALTER, J.S. (1995). Granulocyte-macrophage colony-stimulating factor mRNA stabilization enhances transgenic expression in normal cells and tissues. Blood 86, 2551-2558.
16. ROSENBERG, S.A., YANG, J.C., TOPALIAN, S.L., SCHWARTZENTRUBER, D.J., WEBER, J.S., PARKINSON, D.R., SEIPP, C.A., EINHORN, J.H., and WHITE, D.E. (1994). Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high dose bolus interleukin-2. J. Am. Med. Assoc. A 271, 907-13.
17. SCHILLER, J.H., HANK, J.A., STORER, B., BORCHERT, A.A., HUSEBY-MOORE, K.H., ALBERTINI, M., BECHHOFER, R., WESLEY, O., BROWN, R.R., BASTIN, A.M., and SONDEL, P.M. (1993). A direct comparison of immunological and clinical effects of interleukin-2 with and without interferon-α in humans. Cancer Res. 53, 1286-1292.
18. SCHILLER, J.H., HANK, J.A., KHORSAND, M., STORER, B., BORCHERT, A.A., HUSEBY-MOORE, K.H., BURNS, D., WESLEY, O., ALBERTINI, M., WILDING, G., and SONDEL, P.M. (1995). Clinical and immunologic effects of GM-CSF co-administered with IL-2, a phase I-B study. Clin. Cancer Res. 14, 1912-1921.
19. SCHMIDT, W., SCHWEIGHOFFER, T., HERBST, E., MAASS, G., BERGER, M., SCHILCHER, F., SCHAFFNER, G., and BIRNSTIEL, M.L. (1995). Cancer vaccines: The interleukin-2 dosage effect. Proc. Natl. Acd. Sci. USA 92, 4711-4714.
20. SOSMAN, J.A., KOHLER, P.C., HANK, J.A., MOORE, K.H., BECHHOFER, R., STORER, B., and SONDEL, P.M. (1988). Repetitive weekly cycles of Interleukin-2. II. Clinical and immunologic effects of dose, schedule, and indomethacin. J. Natl. Cancer Inst. 80, 1451-1460.
21. SOSMAN, J.A., KOHLER, P.C., HANK, J.A., MOORE, K.H., BECHHOFER, R., STORER, B., and SONDEL, P.M. (1988). Repetitive weekly cycles of recombinant human interleukin-2: Responses of renal carcinoma with acceptable toxicity. J. Natl. Cancer Inst. 80, 60-63.
22. SUN, W.H., BURKHOLDER, J.K., SUN, J., CULP, J., TURNER, J., LU, X.G., PUGH, T.D., ERSHLER, W.B., and YANG, N.-S. (1995). In vivo cytokine gene transfer by gene gun suppresses tumor growth in mice. Proc. Natl. Acad. Sci. USA 92, 2889-2893.
23. THOMPSON, J.A., SHULMAN, K.L., BENYUNES, M.C., LINDGREN, C.G., COLLINS, C., LANGE, P.H., BUSH, W.H., LINDGREN, C.L., BENZ, L.A., and FEFER, A. (1992). Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer cell therapy for metastatic renal cell carcinoma. J. Clin. Oncol. 10, 960-968.
24. THOMPSON, T.A., GOULD, M.N., BURKHOLDER, J.K., and YANG, N.-S. (1993). Transient promoter activity in rat mammary epithelial cells evaluated using particle bombardment gene transfer. In Vitro Cell. Dev. Biol. 29A, 165-170.
25. YANG, N.-S., and SUN, W. (1995). Gene gun and other non-viral approaches for cancer gene therapy. Nature Med. 1, 481-483.
26. YANG, N.-S., BURKHOLDER, J.K., ROBERTS, B., MARTINELL, B., and MCCABE, D. (1990). In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. USA 87, 9568-9572.